Page last updated: 2024-08-24

triazoles and angiotensin ii

triazoles has been researched along with angiotensin ii in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's14 (42.42)18.2507
2000's10 (30.30)29.6817
2010's9 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, SW; Dutton, D; Giacomini, KM; He, LS; Hui, A; Ortiz de Montellano, P; Stearns, R; Voelkel, NF; Wang, HL1
Chang, SW; Chen, CR; Voelkel, NF1
Blaine, EH; Blehm, DJ; Corpus, VM; Huang, HC; Manning, RE; McMahon, EG; Olins, GM; Palomo, MA; Reitz, DB; Schuh, JR1
Brandt, R; Kanowski, U; Kempfert, C; Oddoy, A; Siewert, B1
Ashton, WT; Chang, LL; Chang, RS; Chen, TB; Flanagan, KL; Kivlighn, SD; Lotti, VJ; O'Malley, SS; Siegl, PK; Zingaro, GJ1
Ashton, WT; Chang, LL; Flanagan, K; Gabel, RA; Greenlee, WJ; Kivlighn, SD; Schaffer, LW; Schorn, TW; Siegl, PK; Zingaro, GJ1
Ishidoya, S; Klahr, S; Morrissey, J1
Ashton, WT; Chakravarty, PK; Chang, LL; Chen, TB; Faust, KA; Flanagan, KL; Greenlee, WJ; Hutchins, SM; Naylor, EM; Patchett, AA1
Ashton, WT; Chang, LL; Chang, RS; Chen, TB; Faust, KA; Flanagan, KL; Greenlee, WJ; Lotti, VJ; MacCoss, M; Strelitz, RA1
Blaine, EH; Huang, HC; Koepke, JP; Manning, RE; Olins, GM; Reitz, DB; Smits, GJ1
Ashton, WT; Cantone, CL; Chang, LL; Chang, RS; Chen, TB; Faust, KA; Hutchins, SM; Lotti, VJ; MacCoss, M; Strelitz, RA1
Aiello, S; Konopka, K; Lapinski, R; Noris, M; Perico, N; Remuzzi, G1
Hibler, S; Ibe, BO; Raj, JU1
Biancone, L; Bussolati, B; Cambi, V; Camussi, G; David, S; Foà, R; Mariano, F1
Benter, IF; Estes, A; Gaber, L; Karzoun, NA; Khandekar, Z; Malik, KU; Muthalif, MM; Parmentier, JH; Saeed, AE1
Chaturved, SC; Pandey, SK; Pandya, T; Saxena, AK; Tiwari, M1
Alonso-Galicia, M; Cowley, AW; Greene, AS; Maier, KG; Roman, RJ1
Brown, R; Fredholm, BB; Lai, EY; Mrowka, R; Patzak, A; Persson, AE; Persson, PB; Spielmann, N; Steege, A1
Wang, Q; Wang, W; Wang, Y; Wu, J; Wu, X; Xu, J1
Jackson, EK; Mi, Z1
Guo, J; Hu, Z; Wang, Q; Wu, J; Wu, X; Xu, J; Yin, Z1
Ji, H; Wang, Q; Wang, W; Wang, Y; Wu, X; Xu, J; Yan, T1
Carlström, M; Lai, EY; Patzak, A; Persson, AE1
Akhtar, S; Benter, IF; Dahly-Vernon, AJ; Dunn, KM; Roman, RJ; Yousif, MH1
Bilan, VP; Jackson, EK; Tofovic, DS1
Du, J; Hourani, S; Ledent, C; Li, JM; Thakur, S1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H1
Ballet, S; Buysse, K; Farard, J; Nikolaou, A; Pedersen, DS; Tourwé, D; Vanderheyden, P; Vauquelin, G1
Deng, X; Duan, Q; Hu, Q; Huang, H; Liao, C; Mao, X; Plutzky, J; Qi, J; Sun, Z; Yang, T; Zhang, G; Zhou, H1
Antunes, E; Bonilla-Becerra, SM; Calmasini, FB; de Oliveira, MG; Rojas-Moscoso, JA; Zanesco, A1
Bansal, A; Chen, Z; Das, S; Ganguly, R; Jia, Y; Lanting, L; Leung, A; Mandi, V; Natarajan, R; Reddy, MA; Schones, DE; Senapati, P; Wu, X; Zhang, S1
Huang, T; Lu, P; Sheng, Z; Wang, S; Xu, Y; Yuan, Y1
Li, FD; Li, HH; Nie, H; Ren, HL; Tian, C; Wang, CY; Wang, HX; Zheng, YH1

Reviews

1 review(s) available for triazoles and angiotensin ii

ArticleYear
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 26, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Enalapril; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Macrophages; Monocytes; Rats; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction

1995

Other Studies

32 other study(ies) available for triazoles and angiotensin ii

ArticleYear
Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstriction.
    The American journal of physiology, 1992, Volume: 263, Issue:4 Pt 1

    Topics: Angiotensin II; Animals; Aorta; Chloramphenicol; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Electric Stimulation; Hypoxia; In Vitro Techniques; Lung; Male; Metyrapone; Papillary Muscles; Pulmonary Circulation; Rabbits; Rats; Triazoles; Vasoconstriction

1992
Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 73, Issue:5

    Topics: Angiotensin II; Animals; Azepines; Hypoxia; In Vitro Techniques; Male; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Edema; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction; Vasodilation

1992
In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:3

    Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cell Membrane; Female; Imidazoles; Kidney; Losartan; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Renin; Tetrazoles; Triazoles; Uterus

1992
[Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
    Pneumologie (Stuttgart, Germany), 1991, Volume: 45, Issue:10

    Topics: Angiotensin II; Animals; Azepines; Hypoxia; Organ Culture Techniques; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Rats; Triazoles; Vasoconstriction

1991
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
    Journal of medicinal chemistry, 1995, Sep-15, Volume: 38, Issue:19

    Topics: Administration, Oral; Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Humans; Mesencephalon; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Sulfonamides; Triazoles

1995
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1995, Volume: 17, Issue:6

    Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dogs; Female; Hypertension; Imidazoles; Kidney; Losartan; Macaca mulatta; Male; Natriuresis; Pan troglodytes; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin; Tetrazoles; Triazoles

1995
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.
    Journal of medicinal chemistry, 1994, Aug-19, Volume: 37, Issue:17

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Indicators and Reagents; Kinetics; Magnetic Resonance Spectroscopy; Male; Mesencephalon; Molecular Structure; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Sulfonamides; Triazoles

1994
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones.
    Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

    Topics: Angiotensin II; Animals; Binding Sites; Male; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles

1993
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
    American journal of hypertension, 1993, Volume: 6, Issue:7 Pt 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Triazoles

1993
Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
    Journal of medicinal chemistry, 1993, Mar-05, Volume: 36, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Blood Pressure; Male; Molecular Structure; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Triazoles

1993
Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney.
    Journal of the American Society of Nephrology : JASN, 1997, Volume: 8, Issue:9

    Topics: Angiotensin II; Animals; Azepines; Dexamethasone; Glucocorticoids; In Vitro Techniques; Kidney; Male; Perfusion; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proteinuria; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles

1997
Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb.
    Journal of applied physiology (Bethesda, Md. : 1985), 1998, Volume: 85, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Azepines; Blood Pressure; Female; Muscle Tonus; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pregnancy; Pulmonary Circulation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Triazoles; Vascular Resistance; Vasoconstrictor Agents

1998
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change.
    The American journal of pathology, 1999, Volume: 154, Issue:2

    Topics: Angiotensin II; Azepines; Cell Size; Cells, Cultured; Cytoskeleton; Dose-Response Relationship, Drug; Glomerular Mesangium; Humans; Interleukin-12; Interleukin-8; Lipopolysaccharides; Platelet Activating Factor; Platelet Aggregation Inhibitors; Receptors, Interleukin; Receptors, Interleukin-12; RNA, Messenger; Superoxides; Time Factors; Triazoles; Tumor Necrosis Factor-alpha

1999
Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4

    Topics: Alkyl and Aryl Transferases; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Flavonoids; Hypertension; Kidney; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mixed Function Oxygenases; ras Proteins; Rats; Rats, Sprague-Dawley; Triazoles

2000
3-D QSAR studies of triazolinone based balanced AT1/AT2 receptor antagonists.
    Bioorganic & medicinal chemistry, 2001, Volume: 9, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding Sites; Brain; Expert Systems; Inhibitory Concentration 50; Models, Molecular; Quantitative Structure-Activity Relationship; Rabbits; Triazoles

2001
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 283, Issue:1

    Topics: Amides; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfones; Triazoles; Vasoconstriction; Vasoconstrictor Agents

2002
Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction.
    Kidney international, 2006, Volume: 70, Issue:4

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Angiotensin II; Animals; Arterioles; Feedback; Female; Kidney Glomerulus; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenethylamines; Purines; Receptor, Adenosine A1; Receptors, Adenosine A2; Theophylline; Triazines; Triazoles; Vasoconstriction; Vasodilation

2006
[Ca2+]i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro.
    Biochemical and biophysical research communications, 2007, Dec-07, Volume: 364, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Calcium; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Protein Kinase C-alpha; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Triazoles

2007
Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6

    Topics: Angiotensin II; Animals; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Hypertension, Renal; Kidney; Male; Neuropeptide Y; Peptide Fragments; Pyrazines; Rats; Rats, Inbred SHR; Renal Circulation; Sitagliptin Phosphate; Sympathetic Nervous System; Triazoles; Vasoconstrictor Agents

2008
Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Cattle; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Injections, Intravenous; Liver; Losartan; Male; Protein Binding; Pyrroles; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Time Factors; Triazoles; Vasoconstriction

2008
PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells.
    Biochemical and biophysical research communications, 2008, Oct-10, Volume: 375, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Cells, Cultured; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Kinase C; Rabbits; Tetrazoles; Triazoles

2008
Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium.
    Acta physiologica (Oxford, England), 2009, Volume: 196, Issue:4

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Calcium; Cytosol; Kidney; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Naphthyridines; Purines; Receptor, Adenosine A1; Receptor, Angiotensin, Type 1; Receptors, Adenosine A2; Triazines; Triazoles; Vasoconstriction

2009
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
    Autonomic & autacoid pharmacology, 2009, Volume: 29, Issue:1-2

    Topics: Amidines; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbachol; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Histamine; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mesenteric Arteries; Microsomes; Nitroprusside; Norepinephrine; Perfusion; Rats; Rats, Wistar; Renal Artery; Triazoles; Vasoconstriction; Vasodilation

2009
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7

    Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hypertension; Kidney; Male; Metabolic Syndrome; Proteinuria; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Sitagliptin Phosphate; Triazoles; Vasoconstriction; Vasoconstrictor Agents

2010
Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells.
    The Journal of biological chemistry, 2010, Dec-17, Volume: 285, Issue:51

    Topics: Adenosine A2 Receptor Antagonists; Angiotensin II; Animals; Cells, Cultured; Endothelial Cells; Enzyme Activation; Gene Expression Regulation, Enzymologic; Membrane Glycoproteins; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 2; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Reactive Oxygen Species; Receptor, Adenosine A2A; Signal Transduction; Triazoles

2010
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 300, Issue:6

    Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles

2011
Amino triazolo diazepines (Ata) as constrained histidine mimics.
    Organic letters, 2011, Dec-16, Volume: 13, Issue:24

    Topics: Amino Acids; Angiotensin II; Azepines; Dipeptides; Histidine; Molecular Structure; Triazoles

2011
Inhibition of BET bromodomain attenuates angiotensin II induced abdominal aortic aneurysm in ApoE
    International journal of cardiology, 2016, Nov-15, Volume: 223

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Azepines; Cells, Cultured; Disease Models, Animal; Extracellular Matrix; Female; Gene Expression Regulation; Humans; Male; Metalloproteases; Mice; Mice, Inbred C57BL; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA; Triazoles

2016
Micturition dysfunction in four-month old ovariectomized rats: Effects of testosterone replacement.
    Life sciences, 2017, Jun-15, Volume: 179

    Topics: Acetanilides; Androgens; Angiotensin II; Animals; Carbachol; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Injections, Intramuscular; Letrozole; Muscle, Smooth; Nitriles; Ovariectomy; Postmenopause; Rats; Rats, Sprague-Dawley; Testosterone; Thiazoles; Triazoles; Urethra; Urination Disorders

2017
Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells.
    Nature communications, 2017, 11-13, Volume: 8, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Azepines; Cells, Cultured; Gene Expression Regulation; Histones; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; RNA, Long Noncoding; Signal Transduction; Triazoles

2017
XPO1-mediated nuclear export of RNF146 protects from angiotensin II-induced endothelial cellular injury.
    Biochemical and biophysical research communications, 2018, 09-10, Volume: 503, Issue:3

    Topics: Acrylates; Angiotensin II; Cell Nucleus; Cells, Cultured; Exportin 1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Karyopherins; L-Lactate Dehydrogenase; Oxidative Stress; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Triazoles; Ubiquitin-Protein Ligases

2018
Chemokine (C-X-C motif) receptor 2 blockade by SB265610 inhibited angiotensin II-induced abdominal aortic aneurysm in Apo E
    Heart and vessels, 2019, Volume: 34, Issue:5

    Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Humans; Macrophages; Male; Mice; Mice, Knockout, ApoE; Phenylurea Compounds; Receptors, Interleukin-8B; Signal Transduction; Triazoles

2019